These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Astragaloside IV promotes the eNOS/NO/cGMP pathway and improves left ventricular diastolic function in rats with metabolic syndrome. Lin X; Wang Q; Sun S; Xu G; Wu Q; Qi M; Bai F; Yu J J Int Med Res; 2020 Jan; 48(1):300060519826848. PubMed ID: 30843445 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying vasorelaxant action of astragaloside IV in isolated rat aortic rings. Zhang C; Wang XH; Zhong MF; Liu RH; Li HL; Zhang WD; Chen H Clin Exp Pharmacol Physiol; 2007; 34(5-6):387-92. PubMed ID: 17439405 [TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Zhang WD; Chen H; Zhang C; Liu RH; Li HL; Chen HZ Planta Med; 2006 Jan; 72(1):4-8. PubMed ID: 16450288 [TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways. Zhang WD; Zhang C; Wang XH; Gao PJ; Zhu DL; Chen H; Liu RH; Li HL Planta Med; 2006 Jun; 72(7):621-6. PubMed ID: 16732512 [TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV Improves Vasodilatation Function by Regulating the PI3K/Akt/eNOS Signaling Pathway in Rat Aorta Endothelial Cells. Lin XP; Cui HJ; Yang AL; Luo JK; Tang T J Vasc Res; 2018; 55(3):169-176. PubMed ID: 29972829 [TBL] [Abstract][Full Text] [Related]
8. Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats. Yin Y; Qi F; Song Z; Zhang B; Teng J Biosci Trends; 2014 Aug; 8(4):217-26. PubMed ID: 25224628 [TBL] [Abstract][Full Text] [Related]
9. Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo. Xu XL; Ji H; Gu SY; Shao Q; Huang QJ; Cheng YP Eur J Pharmacol; 2007 Jul; 568(1-3):203-12. PubMed ID: 17509559 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, and visceral adiposity in fructose-fed hypertensive rats. Chou CL; Pang CY; Lee TJ; Fang TC PLoS One; 2015; 10(3):e0119843. PubMed ID: 25774877 [TBL] [Abstract][Full Text] [Related]
11. Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome. Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A; Marciniak A Life Sci; 2009 Oct; 85(15-16):557-67. PubMed ID: 19686764 [TBL] [Abstract][Full Text] [Related]
12. Protective Effect of Astragaloside IV on High Glucose-Induced Endothelial Dysfunction via Inhibition of P2X7R Dependent P38 MAPK Signaling Pathway. Leng B; Li C; Sun Y; Zhao K; Zhang L; Lu ML; Wang HX Oxid Med Cell Longev; 2020; 2020():5070415. PubMed ID: 33014270 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of non-quinazoline α Kubacka M; Kotańska M; Szafarz M; Pociecha K; Waszkielewicz AM; Marona H; Filipek B; Mogilski S Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):751-760. PubMed ID: 31133498 [TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway. Leng B; Tang F; Lu M; Zhang Z; Wang H; Zhang Y Life Sci; 2018 Sep; 209():111-121. PubMed ID: 30081006 [TBL] [Abstract][Full Text] [Related]
16. Increasing angiotensin-(1-7) levels in the brain attenuates metabolic syndrome-related risks in fructose-fed rats. Guimaraes PS; Oliveira MF; Braga JF; Nadu AP; Schreihofer A; Santos RA; Campagnole-Santos MJ Hypertension; 2014 May; 63(5):1078-85. PubMed ID: 24516106 [TBL] [Abstract][Full Text] [Related]
17. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Wu LY; Juan CC; Hwang LS; Hsu YP; Ho PH; Ho LT Eur J Nutr; 2004 Apr; 43(2):116-24. PubMed ID: 15083319 [TBL] [Abstract][Full Text] [Related]
18. Effect of bromocriptine on cardiovascular complications associated with metabolic syndrome in fructose fed rats. Nade VS; Kawale LA; Todmal UB; Tajanpure AB Indian J Pharmacol; 2012; 44(6):688-93. PubMed ID: 23248395 [TBL] [Abstract][Full Text] [Related]
19. Vasorelaxant action of an ethylacetate fraction of Euphorbia humifusa involves NO-cGMP pathway and potassium channels. Wang TT; Zhou GH; Kho JH; Sun YY; Wen JF; Kang DG; Lee HS; Cho KW; Jin SN J Ethnopharmacol; 2013 Jul; 148(2):655-63. PubMed ID: 23707330 [TBL] [Abstract][Full Text] [Related]
20. Importance of cyclooxygenase 2-mediated low-grade inflammation in the development of fructose-induced insulin resistance in rats. Liu TT; Shih KC; Kao CC; Cheng WT; Hsieh PS Chin J Physiol; 2009 Apr; 52(2):65-71. PubMed ID: 19764341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]